Refine by
Pharmabcine Immuno Oncology Services
1 services found
Manufactured by:PharmAbcine Inc. based inYuseong-gu, SOUTH KOREA
Depending on antigen presentation patterns on target cell types and the related drug MOA, various bispecific platforms (DIG-body, PIG-body and TIG-body) are adopted in our antibody engineering strategy. Currently, immuno-oncology assets like PMC-122a (anti-PD-L1 x SIRPa) and PMC-122b (anti-PD-L1 x anti-CD47) are currently under early development ...